文献速递膀胱癌与上尿路尿路上皮癌

上尿路尿路上皮癌患者临床淋巴结分期的诊断准确性:一项多中心、回顾性、观察性研究

Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study.
PubMed 文献 · J Urol · 2022-12-07

该多中心回顾性观察研究纳入865例非转移性上尿路尿路上皮癌患者,术前均行常规横断面影像学检查并接受根治性手术及淋巴结清扫。临床淋巴结分期(cN)与病理淋巴结分期(pN)一致性为74%,cN分期敏感度仅25%(95%CI 20;31),特异度91%(95%CI 88;93),曲线下面积0.58(95%CI 0.55;0.61),提示诊断准确性低。

要点

  • 常规横断面影像学对pN+病变敏感度低(25%,95%CI 20;31),特异度91%(95%CI 88;93)。
  • cN+者pN+可能性增加近3倍,阳性似然比2.7(95%CI 2.0;3.8),阴性似然比0.83(95%CI 0.76;0.89)。
  • cN与pN一致性74%,病理降期6.8%,升期19%。

核心结论

  • 常规横断面影像学检测上尿路尿路上皮癌pN+病变敏感度低,但cN+使pN+可能性增加近3倍,因此该检查是规则入(rule-in)而非规则排除(rule-out)试验。
  • 上尿路尿路上皮癌根治性手术中应保留淋巴结清扫以获得准确N分期;cN+可作为早期全身治疗的有力依据。

研究设计与样本

  • 多中心、回顾性、观察性研究,纳入865例非转移性(M0)上尿路尿路上皮癌患者,术前接受常规横断面影像学分期并接受根治性手术及淋巴结清扫。

主要发现

  • 常规横断面影像学将750例归为cN0、115例归为cN+;淋巴结清扫将641例归为pN0、224例归为pN+。
  • cN分期与病理分期一致者74%,病理降期6.8%,升期19%。
  • cN分期敏感度25%(95%CI 20;31),特异度91%(95%CI 88;93)。
  • 阳性似然比2.7(95%CI 2.0;3.8),阴性似然比0.83(95%CI 0.76;0.89)。
  • 受试者工作特征曲线下面积0.58(95%CI 0.55;0.61),提示诊断准确性低。

临床怎么用

  • 常规横断面影像学是规则入而非规则排除试验,cN+增加pN+可能性近3倍。
  • 上尿路尿路上皮癌根治性手术中应保留淋巴结清扫以获得准确N分期。
  • cN+可作为早期全身治疗的有力依据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Treatment options for the management of upper tract urothelial cancer are based on accurate staging. However, the performance of conventional cross-sectional imaging for clinical lymph node staging (N-staging) remains poorly investigated. This study aims to evaluate the diagnostic accuracy of conventional cross-sectional imaging for upper tract urothelial cancer N-staging. MATERIALS AND METHODS: This study was a multicenter, retrospective, observational study. We included 865 nonmetastatic (M0) upper tract urothelial cancer patients treated with curative intended surgery and lymph node dissection who had been staged with conventional cross-sectional imaging before surgery. We compared clinical (c) and pathological (p) N-staging results to evaluate the concordance of node-positive (N+) and node-negative (N0) disease and calculate cN-staging's diagnostic accuracy. RESULTS: Conventional cross-sectional imaging categorized 750 patients cN0 and 115 cN+. Lymph node dissection categorized 641 patients pN0 and 224 pN+. The cN-stage was pathologically downstaged in 6.8% of patients, upstaged in 19%, and found concordant in 74%. The sensitivity and specificity of cN-staging were 25% (95% CI 20; 31) and 91% (95% CI 88; 93). Positive and negative likelihood ratios were 2.7 (95% CI 2.0; 3.8) and 0.83 (95% CI 0.76; 0.89). The area under the receiver operating characteristics curve (0.58, 95% CI 0.55; 0.61) revealed low diagnostic accuracy. CONCLUSIONS: Conventional cross-sectional imaging had low sensitivity in detecting upper tract urothelial cancer pN+ disease. However, cN+ increased the likelihood of pN+ by almost threefold. Thus, conventional cross-sectional imaging is a rule-in but not a rule-out test. Lymph node dissection should remain the standard during extirpative upper tract urothelial cancer surgery to obtain accurate N-staging. cN+ could be a strong argument for early systemic treatment.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Pallauf M, D'Andrea D, König F, et al. Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study. J Urol. 2022. PMID: 36475808. doi:10.1097/JU.0000000000003085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。